CCP Approves Acquisition of Two Japanese Pharmaceutical Products by Hilton Pharma
ISLAMABAD. The Competition Commission of Pakistan (CCP) has approved the acquisition of two pharmaceutical products of M/s Eisai Co. ltd, a Tokyo-based firm, by M/s Hilton Pharma Pvt ltd. The proposed transaction entails acquisition of two pharmaceutical products i.e. ‘Methycobal and Myonal’ including their trademarks, know-how and records in terms of assets consequent to an…